Sign up to save your podcasts
Or
Share Are GLP-1s the Miracle Drug?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Are GLP-1s the Miracle Drug?
Episode 5: Are GLP-1S the Wonder Drug?
About This Episode:
In this episode, Dr. Drew Crawford examines the rapid rise of GLP-1 receptor agonists as transformative treatments for obesity and type 2 diabetes. He highlights their ability to suppress appetite, regulate blood sugar, and promote significant weight loss, while also addressing potential side effects and the importance of integrating these medications with sustainable lifestyle changes. The episode offers a balanced perspective on whether these drugs are a medical breakthrough or part of a broader, long-term health strategy.
Show Notes:
- 1:07 - What are GLP-1s and What Do They Do?
- 7:07 - The Benefits of GLP-1s
- 8:01 - The Adverse Effects of GLP-1s
- 11:10 - Common Reasons Why Patients Should Not Take These Medications
- 12:53 - Who Should Be Monitored?
- 16:24 - Liraglutide versus Semaglutide
- 18:09 - Study #1
- 20:13 - Study #2
- 22:54 - Study #3
- 23:32 - Should GLP-1s Be A Long-Term Treatment?
About Your Host:
Dr. Drew Crawford is a board-certified gastroenterologist with an active practice in Tulsa, Oklahoma. He also serves as the Program Director for the Gastroenterology Fellowship at Oklahoma State University. Additionally, and more relevant to this podcast, Dr. Drew Crawford is board-certified in obesity medicine. In the BMI Podcast, we will go Beyond Measurements & Image to build healthier lifestyles, elevate your well-being, and transform lives!
The BMI Podcast Resources:
Instagram (@the.bmi.podcast)
Facebook (TheBMIPodcast)
X (Twitter) (@thebmipodcast)
LinkedIn (Andrew (Drew) Crawford, DO, MBA, DABOM)
Website (www.thebmipodcast.com)
The BMI Podcast Disclaimer:
The BMI Podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
View all episodes
By Dr. Drew CrawfordEpisode 5: Are GLP-1S the Wonder Drug?
About This Episode:
In this episode, Dr. Drew Crawford examines the rapid rise of GLP-1 receptor agonists as transformative treatments for obesity and type 2 diabetes. He highlights their ability to suppress appetite, regulate blood sugar, and promote significant weight loss, while also addressing potential side effects and the importance of integrating these medications with sustainable lifestyle changes. The episode offers a balanced perspective on whether these drugs are a medical breakthrough or part of a broader, long-term health strategy.
Show Notes:
- 1:07 - What are GLP-1s and What Do They Do?
- 7:07 - The Benefits of GLP-1s
- 8:01 - The Adverse Effects of GLP-1s
- 11:10 - Common Reasons Why Patients Should Not Take These Medications
- 12:53 - Who Should Be Monitored?
- 16:24 - Liraglutide versus Semaglutide
- 18:09 - Study #1
- 20:13 - Study #2
- 22:54 - Study #3
- 23:32 - Should GLP-1s Be A Long-Term Treatment?
About Your Host:
Dr. Drew Crawford is a board-certified gastroenterologist with an active practice in Tulsa, Oklahoma. He also serves as the Program Director for the Gastroenterology Fellowship at Oklahoma State University. Additionally, and more relevant to this podcast, Dr. Drew Crawford is board-certified in obesity medicine. In the BMI Podcast, we will go Beyond Measurements & Image to build healthier lifestyles, elevate your well-being, and transform lives!
The BMI Podcast Resources:
Instagram (@the.bmi.podcast)
Facebook (TheBMIPodcast)
X (Twitter) (@thebmipodcast)
LinkedIn (Andrew (Drew) Crawford, DO, MBA, DABOM)
Website (www.thebmipodcast.com)
The BMI Podcast Disclaimer:
The BMI Podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.